PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.55%
Revenue growth under 50% of MCHP's 13.94%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.98%
Gross profit growth under 50% of MCHP's 16.96%. Michael Burry would be concerned about a severe competitive disadvantage.
-0.34%
Negative EBIT growth while MCHP is at 38.46%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.34%
Negative operating income growth while MCHP is at 38.46%. Joel Greenblatt would press for urgent turnaround measures.
1.09%
Net income growth under 50% of MCHP's 56.76%. Michael Burry would suspect the firm is falling well behind a key competitor.
8.33%
EPS growth under 50% of MCHP's 25.56%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
8.33%
Diluted EPS growth under 50% of MCHP's 25.56%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.53%
Share reduction more than 1.5x MCHP's 25.41%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.43%
Diluted share reduction more than 1.5x MCHP's 25.41%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
28.73%
Dividend growth of 28.73% while MCHP is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
36.43%
OCF growth above 1.5x MCHP's 11.58%. David Dodd would confirm a clear edge in underlying cash generation.
170.27%
Positive FCF growth while MCHP is negative. John Neff would see a strong competitive edge in net cash generation.
75.71%
10Y CAGR of 75.71% while MCHP is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
25.80%
5Y CAGR of 25.80% while MCHP is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
21.91%
3Y CAGR of 21.91% while MCHP is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32045.29%
3Y OCF/share CAGR of 32045.29% while MCHP is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
282.66%
10Y net income/share CAGR of 282.66% while MCHP is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
115.17%
Net income/share CAGR of 115.17% while MCHP is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
232.45%
3Y net income/share CAGR of 232.45% while MCHP is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
-12.64%
Negative 5Y equity/share growth while MCHP is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
7.50%
Equity/share CAGR of 7.50% while MCHP is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
32.23%
Dividend/share CAGR of 32.23% while MCHP is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-78.93%
Negative near-term dividend growth while MCHP invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
0.83%
AR growth is negative/stable vs. MCHP's 27.53%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-1.58%
Inventory is declining while MCHP stands at 3.81%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.49%
Asset growth well under 50% of MCHP's 49.28%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
6.43%
Under 50% of MCHP's 23.92%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.04%
We’re deleveraging while MCHP stands at 74.19%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.61%
SG&A growth well above MCHP's 6.67%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.